Navigation Links
Moderate Consumption Of Nuts Could Prevent The Risk Of Heart Disease

Doctors are of the opinion that eating nuts about twice a week might reduce the risk of heart disease significantly.//

The study that was presented at the World Congress of Cardiology stated that as little as two servings of eight grams of nuts that would be around a small plate full might reduce the risk of heart disease by as much as 11%.

Another survey confirmed that eating a small quantity of the same kinds of nuts five days a week only results in a little bit of weight gain.

The latest study is part of a larger European study that had begun 10 years ago, to discover the connection between diet, cancer and heart disease. The varieties of nuts that have been included in the study were almonds, walnuts, cashews, Brazilian nuts and traditional peanuts. Yet another study had previously also confirmed that the consumption of a small amount of these same nuts 5 days a week could only cause a very little weight gain.

Professor Elio Riboli, professor of cancer epidemiology at Imperial College, London said, 'You could say that a modest consumption of nuts contributed to reducing myocardial infarction. He did however stated that “But there is no point sitting in front of the TV, being obese and having high blood pressure and expecting nuts to protect you against a heart attack.'
VIK
'"/>




Page: 1

Related medicine news :

1. Moderate Use of Analgesics - Not Associated With Kidney Dysfunction
2. Moderate alcohol consumption protects against dementia
3. Moderate Exercise may not help prevent Heart Disease
4. The Benefits Of A Diet Consisting Of Moderate Amounts Of Fat
5. Moderate drinking can be good for the kidneys
6. Enjoy Moderate Exercise and Keep Your Heart Fit
7. Even Moderate Drinking Is Not Good For The Heart
8. Moderate Drinkers Found to Escape Obesity and Related Problems
9. Moderate Exercise Is Good For The Heart: Study
10. Moderate Drinking Can Help Cut Diabetes Risk In Middle-Aged Women
11. Moderate Drinking Does Not Guard Against Heart Disease
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/24/2017)... ... April 24, 2017 , ... Miami ... attending the 2017 Oral Reconstruction Foundation’s 2017 Symposium on Tissue Regeneration and Implant ... will present its annual Global Symposium at the Fontainebleau Hotel located in Miami ...
(Date:4/24/2017)... ... April 24, 2017 , ... Anaconda BioMed, ... neuro-thrombectomy systems for the treatment of Acute Ischemic Stroke (AIS), today announced it ... as the product advances towards regulatory and clinical phases. , "This is another ...
(Date:4/23/2017)... ... April 23, 2017 , ... Altura ... the achievement of Cisco Select certification and SMB specialization. Altura is now ... , In earning the Select Certification, Altura fulfilled the training and exam ...
(Date:4/22/2017)... ... April 22, 2017 , ... PharmacyChecker.com released its first ... average of 70% when buying medication online from Canadian pharmacies verified in the ... from other countries. The report (chart below) compares U.S. and foreign prices for ...
(Date:4/21/2017)... ... April 21, 2017 , ... An April 10 article in the ... which reveal a great deal about prehistoric ice-age dental practitioners and their primitive and, ... used to remove decayed dental matter, and that teeth were then filled with bitumen, ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... Inc ., a digital health company focused on modernizing and ... $25 million in Series B funding led by Qiming US ... Seattle that is part of a broader family ... included participation from SR One , who led ZappRx,s ... Google Ventures). As part of the financing, Mark McDade ...
(Date:4/20/2017)... Research and Markets has announced the ... Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies ... ... was valued at US$ 7,167.6 Mn in 2015, and is ... a CAGR of 5.6% from 2016 to 2024. ...
(Date:4/20/2017)... 20, 2017 NeuroVive Pharmaceutical AB (Nasdaq ... positive preclinical results demonstrating anti-fibrotic effects with ... steatohepatitis (NASH), in an additional well-validated experimental ... has previously shown similar anti-fibrotic effects in ... scientists present novel data demonstrating anti-fibrotic effects ...
Breaking Medicine Technology: